ReCode Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in ReCode Therapeutics?

ReCode Therapeutics has 18 investors including Cystic Fibrosis Foundation And OrbiMed.

Q: How much funding has ReCode Therapeutics raised to date?

ReCode Therapeutics has raised obfuscated.

Overview

ReCode Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About ReCode Therapeutics

CB Rank

7406

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

Founded

obfuscation

Private

Debt Financing

Dallas, Texas, United States

11-50

recodetx.com

Biopharma

Biotechnology

Genetics

Medical

Pharmaceutical

Therapeutics

Funding Rounds

Debt Financing

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Series B

OBF

obfuscation

Key People

Daniel Siegwart: Co-Founder
Philip Thomas: Co-Founder

Details

Legal Name

ReCode Therapeutics, Inc.

Also Known As

ReCode

Operating Status

Active

Company Type

For Profit

Founders

Daniel Siegwart, Michael Torres, Philip Thomas

About the Company

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics. Its selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. The company aims to leverage innovative technologies to

provide solutions for individuals affected by genetic diseases.

Phone Number

469-306-1618

Contact Email

info@recodetx.com

Diversity Spotlight

Women Led

Predictions & Insights

Growth Insight

See this Growth Insight

ReCode Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Selective Organ Targeting (SORT) Lipid Nanoparticle (LNP) Platform

A modular lipid nanoparticle delivery system engineered to target genetic medicines to specific organs, tissues, and cells beyond the liver via various administration routes.

RCT1100

An inhaled mRNA-based therapeutic candidate targeting primary ciliary dyskinesia caused by mutations in the DNAI1 gene.

Research & Development

ReCode Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Debt Financing - ReCode Therapeutics	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - ReCode Therapeutics	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - ReCode Therapeutics	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - ReCode Therapeutics	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - ReCode Therapeutics	—	obfuscated obfuscation	—	Debt Financing

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Debt Financing - ReCode Therapeutics	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - ReCode Therapeutics	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - ReCode Therapeutics	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - ReCode Therapeutics	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - ReCode Therapeutics	—	obfuscated obfuscation	—	Debt Financing

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Cystic Fibrosis Foundation	Yes	Venture Round - ReCode Therapeutics	—
Cystic Fibrosis Foundation	Yes	Venture Round - ReCode Therapeutics	—
Cystic Fibrosis Foundation	Yes	Venture Round - ReCode Therapeutics	—
Cystic Fibrosis Foundation	Yes	Venture Round - ReCode Therapeutics	—
Cystic Fibrosis Foundation	Yes	Venture Round - ReCode Therapeutics	—